Unrecognized Tax Benefits in USD of Fulgent Genetics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Fulgent Genetics, Inc. quarterly Unrecognized Tax Benefits history and change rate from Q3 2020 to Q3 2025.
  • Fulgent Genetics, Inc. Unrecognized Tax Benefits for the quarter ending 30 Sep 2025 was $6,783,000, a 7.2% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,783,000 +$457,000 +7.2% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $4,838,000 -$1,457,000 -23% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $4,700,000 -$1,278,000 -21% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $4,563,000 -$1,415,000 -24% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $6,326,000 -$3,229,000 -34% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $6,295,000 -$3,541,000 -36% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $5,978,000 -$3,858,000 -39% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $5,978,000 -$3,858,000 -39% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $9,555,000 +$7,729,000 +423% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $9,836,000 +$8,106,000 +469% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $9,836,000 +$8,626,000 +713% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $9,836,000 +$9,111,000 +1257% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $1,826,000 +$1,292,000 +242% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,730,000 +$1,225,000 +243% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $1,210,000 +$736,000 +155% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $725,000 +$348,000 +92% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $534,000 +$145,000 +37% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $505,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $474,000 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $377,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $389,000 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.